New Products: Agilent's Clinical Research Exome; Qiagen's GeneRead Panels; More | GenomeWeb

Agilent Technologies has launched its SureSelect Clinical Research Exome, which it developed in collaboration with researchers from Emory University and the Children’s Hospital of Philadelphia. It uses Agilent's SureSelect Human All Exon V5 as the core, but includes 10 percent deeper coverage and enhanced performance in disease-associated regions, including targets identified in OMIM, HGMD, and ClinVar databases. The kit targets around 54 mb of content.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.